APA (7th ed.) Citation

PJ, M., RB, W., P, N., JM, G., N, L., D, W., . . . IB, M. (2026). Correction: Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison. Rheumatology and therapy, 13(3), 881. https://doi.org/10.1007/s40744-026-00831-8

Chicago Style (17th ed.) Citation

PJ, Mease, Warren RB, Nash P, Grouin JM, Lyris N, Willems D, Taieb V, Eells J, and McInnes IB. "Correction: Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison." Rheumatology and Therapy 13, no. 3 (2026): 881. https://doi.org/10.1007/s40744-026-00831-8.

MLA (9th ed.) Citation

PJ, Mease, et al. "Correction: Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison." Rheumatology and Therapy, vol. 13, no. 3, 2026, p. 881, https://doi.org/10.1007/s40744-026-00831-8.